George Soros Clovis Oncology, Inc. Transaction History

Soros Fund Management LLC

  • $4.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$4.82 - $7.72 $69,759 - $111,731
-14,473 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$5.69 - $9.69 $446,249 - $759,957
-78,427 Reduced 84.42%
14,473 $98,000
Q1 2020

May 15, 2020
BUY
$3.77 - $11.0 $350,233 - $1.02 Million
92,900 New
92,900 $591,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track George Soros's Portfolio

Track George Soros Portfolio

Follow George Soros (Soros Fund Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email